The Correlation Between Heart Failure and Gut Microbiome Metabolites

Area of Science:

• Microbiology
• Cardiology
• Metabolomics

Background:

• Heart failure (HF) presents a significant and increasing global health burden.
• The gut microbiome plays a crucial role in human physiological and pathological processes.
• Emerging evidence indicates a strong link between HF and metabolites produced by gut bacteria.

Purpose of the Study:

• To review alterations in gut microbiome metabolites associated with HF.
• To elucidate the connection between these metabolites and HF progression.
• To explore novel therapeutic strategies targeting the gut microbiome for HF treatment.

Main Methods:

• Literature review and synthesis of existing studies on HF and gut microbiome metabolites.
• Analysis of specific metabolite alterations in HF patients.
• Evaluation of the functional roles of these metabolites in HF pathogenesis.

Main Results:

• Specific gut microbiome metabolites are significantly altered in patients with heart failure.
• These metabolite changes correlate with the severity and progression of HF.
• Dysbiosis of the gut microbiome contributes to HF pathophysiology through altered metabolic pathways.

Conclusions:

• Targeting gut microbiome metabolites offers a promising avenue for novel HF therapies.
• Modulating gut microbial metabolism could reduce HF morbidity and mortality.
• Further research into microbiome-based interventions may improve HF prognosis.